Startseite › Nichtkleinzelliges Lungenkarzinom › Illinois › Evanston
Klinische Studien zu Nichtkleinzelliges Lungenkarzinom in Evanston, IL
22 Studien zu Nichtkleinzelliges Lungenkarzinom suchen Teilnehmer an Standorten in und um Evanston (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Teilnehmer gesuchtPhase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi entfernt
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
- und 1 weitere
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Teilnehmer gesuchtPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Teilnehmer gesuchtPhase 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Teilnehmer gesuchtPhase 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Illinois Cancer Specialists, Niles · 6 mi entfernt
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Teilnehmer gesuchtPhase 3
- Illinois Cancer Specialists, Niles · 6 mi entfernt
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Teilnehmer gesuchtPhase 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 2
- Illinois Cancer Specialists /ID# 274678, Niles · 6 mi entfernt
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Teilnehmer gesuchtPhase 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Teilnehmer gesuchtPhase 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · 6 mi entfernt
- Advocate Medical Group Oncology, Park Ridge · 8 mi entfernt
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Teilnehmer gesuchtBeobachtungsstudie
- Orchard Healthcare Research Inc., Skokie · 2 mi entfernt
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Teilnehmer gesuchtPhase 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 mi entfernt
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Teilnehmer gesuchtPhase 3
- Research Site, Niles · 6 mi entfernt
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- Advocate Aurora Health, Park Ridge · 8 mi entfernt
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi entfernt
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Teilnehmer gesuchtBeobachtungsstudie
- Advocate Lutheran General Hospital, Park Ridge · 8 mi entfernt
GEMINI-NSCLC: NSCLC Biomarker Study
Teilnehmer gesuchtBeobachtungsstudie
- Northwestern University, Evanston
Nichtkleinzelliges Lungenkarzinom-Studien in anderen Städten
- Houston, TX145 Studien
- New York City, NY120 Studien
- Arlington, VA104 Studien
- Nashville, TN97 Studien
- Boston, MA90 Studien
- Los Angeles, CA87 Studien
- St. Louis, MO73 Studien
- Chicago, IL61 Studien
- Baltimore, MD60 Studien
- San Antonio, TX59 Studien
- Columbus, OH56 Studien
- Washington, DC55 Studien
Weitere Studien in Evanston
- Lungenkrebs19 Studien
- Brustkrebs13 Studien
- Akute myeloische Leukämie11 Studien
- Adipositas11 Studien
- Kolorektales Karzinom10 Studien
- Krebs (alle Arten)9 Studien
- Übergewicht9 Studien
- Colitis ulcerosa9 Studien
- Prostatakrebs9 Studien
- Morbus Crohn9 Studien
- Herzinsuffizienz8 Studien
- Vorhofflimmern8 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.